EUVIMEDEUVIMED entdecken
Crossref

SATB2 Expression Affects Chemotherapy Metabolism and Immune Checkpoint Gene Expression in Colorectal Cancer

Barry Maguire, Batuhan Kisakol, Jochen H M Prehn, John P Burke

Clinical Colorectal Cancer · 2025

DOI: 10.1016/j.clcc.2024.12.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2025. Verfasst von Barry Maguire und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Beaumont Hospital, Dublin, Ireland; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland; D…. Hauptthemen laut MEDLINE: Matrix Attachment Region Binding Proteins, Colorectal Neoplasms, Transcription Factors, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Health Research Board, EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions, Science Foundation Ireland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Special AT-rich binding protein-2 (SATB2) is a nuclear matrix associated protein regulating gene expression which is normally expressed in colonic tissue. Loss of SATB2 expression in colorectal cancer (CRC) has negative implications for prognosis and has been associated with chemotherapy resistance. Furthermore, recent evidence suggests SATB2 may influence immune checkpoint (IC) expression. We hypothesized that SATB2 expression may be associated with altered expression of chemotherapy resistance associated and IC genes. METHODS: Clinicopathologic and gene expression data were extracted from The Cancer Genome Atlas PanCancer Atlas. SATB2 expression was compared by clinicopathologic characteristic and by using multivariate regression analysis to explore associations with chemotherapy and IC gene expression. RESULTS: About 553 patients were included for analysis. Lower quartile SATB2 expression was associated with worse disease specific survival (P = .04). MSI (P < .001) and mucinous (P < .001) tumors were associated with reduced SATB2 expression independently. SATB2 varied by consensus molecular subtype (P < .001) and was lowest in CMS1. On multivariate analysis, SATB2 was negatively associated with 5-FU related metabolism genes, while more complex but significant relationships were seen with oxaliplatin and irinotecan related genes. Low SATB2 expression was associated with increased expression of PD-1, PD-L1, TIM-3 and CTLA-4 IC genes. CONCLUSION: The positive prognostic influence of SATB2 expression is reaffirmed in this study. This effect may be explained by the negative association between SATB2 and 5-FU-resistance related gene expression. Enhanced IC gene expression in SATB2 low cases suggests a potential role for IC inhibition in this setting, but further study is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Matrix Attachment Region Binding ProteinsColorectal NeoplasmsTranscription FactorsBiomarkers, TumorAntineoplastic Combined Chemotherapy ProtocolsImmune Checkpoint ProteinsHumansMaleFemaleMiddle AgedPrognosisDrug Resistance, NeoplasmAgedGene Expression Regulation, NeoplasticFluorouracil

Stichwörter der Autor:innen

5-fluorouracilCMS1PD-1PD-L1Prognosis

Substanzen

Matrix Attachment Region Binding ProteinsSATB2 protein, humanTranscription FactorsBiomarkers, TumorFluorouracilImmune Checkpoint Proteins

Autor:innen und Institutionen

  • Department of Colorectal Surgery, Beaumont Hospital, Dublin, Ireland; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Physiology and Medical Physics, Royal College of Surgeons…
  • Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Department of Colorectal Surgery, Beaumont Hospital, Dublin, Ireland. Electronic address: johnburke@rcsi.com.

Förderung

  • Health Research Board
  • EU Framework Programme for Research and Innovation Marie Skłodowska-Curie Actions
  • Science Foundation Ireland
  • Royal College of Surgeons in Ireland
  • Higher Education Authority

Zitieren

APA

Maguire, B., Kisakol, B., Prehn, J. H. M., & Burke, J. P. (2025). SATB2 Expression Affects Chemotherapy Metabolism and Immune Checkpoint Gene Expression in Colorectal Cancer. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.12.004

Vancouver

Maguire B, Kisakol B, Prehn JHM, Burke JP. SATB2 Expression Affects Chemotherapy Metabolism and Immune Checkpoint Gene Expression in Colorectal Cancer. Clinical Colorectal Cancer. 2025. doi:10.1016/j.clcc.2024.12.004

BibTeX
@article{Maguire2025,
  author = {Maguire, Barry and Kisakol, Batuhan and Prehn, Jochen H M and Burke, John P},
  title = {SATB2 Expression Affects Chemotherapy Metabolism and Immune Checkpoint Gene Expression in Colorectal Cancer},
  journal = {Clinical Colorectal Cancer},
  year = {2025},
  doi = {10.1016/j.clcc.2024.12.004}
}
Kostenlos starten →